AAPG Ascentage: Quarterly Revenue Growth

Brandmark of Ascentage Pharma Group (AAPG)

The quarterly revenue growth rate reflects sales dynamics, where the value of 0.00 serves as the baseline for the current metric. Ascentage Pharma Group is conducting intensive R&D in oncology, overcoming patent barriers. The company generates revenue from the sale of targeted therapies in China. Currently, the business is focusing on organic growth and seeking global partners for international distribution.

AAPG Ascentage Pharma Corp Sales Growth QoQ (01/25/2025 - 11/20/2026)

Summary analytical data breakdowns for Ascentage Pharma (AAPG)

- stock price and consensus target price:
Comprehensive company analysis:Ascentage Pharma Group International (AAPG)
Manufactured products of ascentage.com

Portfolio managers evaluate the operating model of Ascentage Pharma Group (AAPG) through a daily recalculation of sales growth rates, which separates the actual financial impact from the speculative noise surrounding clinical trials. An analysis of quarterly trading revenue dynamics allows for a comparison of the monetization rates of unique molecules against R&D costs, confirming the sustainability of the company's niche leadership amid fierce regulatory competition.

Main competitors

BeiGene Oncology - Quarterly Revenue Growth|HALO: Revenue Growth QoQ|Revolution Medicines Corp (RVMD) - Revenue Growth QoQ|Quarterly Revenue Growth Rate CG Oncology Inc (CGON)|URGN (urogen.com) - Quarterly Revenue Growth|BCAX: Quarterly Revenue Increase|Revenue Growth QoQ Personalis (PSNL)|Quarterly Revenue Growth Erasca (ERAS)|Quarterly Revenue Growth DCTH (Delcath Systems)|Quarterly Revenue Increase YMAB|AURA - Revenue Growth QoQ|candeltx.com - Sales Change QoQ|ARAY: Quarterly Revenue Growth|Revenue Dynamics QoQ SLS (SELLAS Life Sciences Group, Inc.)|ACTU (Actuate Therapeutics) - Quarterly Revenue Growth|Quarterly Sales Growth Citius Oncology Inc. (CTOR)|Revenue Growth QoQ TuHURA (HURA)|TARA - Quarterly Revenue Growth Rate|Quarterly Revenue Growth FATE (Fate Therapeutics Inc)|Aadi Bioscience Inc (WHWK) - Quarterly Revenue Growth Rate|TScan - Quarterly Revenue Growth|Champions Oncology, Inc. (CSBR) - Quarterly Sales Growth|XBIT (XBiotech Inc.) - Quarterly Sales Growth|CEL-SCI Corporation (CVM) - Quarterly Revenue Growth|Revenue Growth QoQ OS Therapies|RADX: Quarterly Revenue Increase|Revenue Growth QoQ artivabio.com (ARTV)|Quarterly Sales Growth Rate Adlai Nortye|Quarterly Revenue Growth VERU (Veru Corporation)|Sales Change QoQ TPST (Tempest Tx)|XLO: Quarterly Sales Growth|renovarobio.com (RENB) - Quarterly Sales Growth|Mural Bio (MURA) - Revenue Growth QoQ|Kairos Pharma Inc (KAPA) - Quarterly Revenue Growth|Quarterly Sales Growth OKUR|CytoMed Therapeutics (GDTC) - Quarterly Sales Growth Rate|Quarterly Sales Growth CRIS (Curis Inc.)|Quarterly Revenue Growth Apollomics Inc. (APLM)|Revenue Growth QoQ Tharimmune Corp THAR|Advanced Biomed Corp - Revenue Growth QoQ|GNPX: Quarterly Sales Growth|Calidi Biotherapeutics, Inc. (CLDI) - Quarterly Sales Growth|SBFM: Quarterly Revenue Growth|Quarterly Sales Growth Xenetic Biosciences Inc.|Revenue Growth QoQ Salarius Pharmaceuticals Inc|PPBT: Quarterly Revenue Increase|Quarterly Revenue Growth AONC|BGNE (BeOne Medicines) - Quarterly Revenue Increase|Checkpoint Therapeutics, Inc - Quarterly Sales Growth|elevationoncology.com (ELEV) - Quarterly Revenue Growth Rate|iCAD Inc. - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Ikena Oncology|NTBL: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Viracta (VIRX)|MOR (MorphoSys AG) - Quarterly Revenue Growth|NAYA: Quarterly Revenue Increase|Revenue Growth QoQ Ascentage Pharma Group Ltd (AAPGV)